loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

BIO MEDICA LABORATORIES IPO

CLOSED

IPO Details

21th May 2026
25th May 2026
1,000
₹ 264,000
₹ 132-139
₹ 52 Crore

Issue timeline

  • 21-25 May 2026
  • 26-May-2026
  • 27-May-2026
  • 27-May-2026
  • 28-May-2026

Subscription Status

Shareholder -
Qualified Institutional Buyers -
Non-Institutional Investor -
Retail Individual Investor -
Employee -
Total -

About Company

Bio Medica Laboratories was incorporated on August 14, 2015. The company manufactures pharmaceutical injectable formulations for human and veterinary use, operating on a B2B contract manufacturing model. Its portfolio includes liquid and dry powder injections produced under GMP and GLP-certified facilities equipped with advanced quality testing infrastructure
-
Name Designation
Pradeep Mehta Managing Director
Mukesh Mehta Whole Time Director
Surabhi Mahajan Director
Divya Khandelwal Independent Director
Sumeet Bansal Independent Director

Objectives

To meet out the repayment of loan
Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
To meet out the general corporate purposes

Strengths & Risks

Strengths (3)

The company follows strict quality assurance processes supported by GLP and GMP certifications. Its in-house quality control team conducts regular testing of raw materials and finished products to ensure compliance with regulatory and quality standards

Risks (3)

The company depends on a limited number of clients for a significant share of revenue. Loss of any key client or unfavorable contract terms could adversely affect business performance and financial results

Financials

Frequently Asked Questions

What is the issue type for Bio Medica Laboratories Ltd.?

This IPO consists of an offer for sale of up to Rs 5.2 crore, of 377,000 shares. It also consists of a fresh issue of Rs 47.2 crore.

The promoters of the company are Pradeep Mehta and Mukesh Mehta.

The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.

The price band of the IPO is Rs 132.0 - 139.0.

The IPO application opens on May 21, 2026 and closes on May 25, 2026.

View More

*The financials mentioned above are sourced from DRHP/ RHP documents.